Evidence map›Paper›PMID 22297658›Full record

ReviewJournal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract2012

Current strategies and future perspectives for intraperitoneal adhesion prevention.

Christoph Brochhausen, Volker H Schmitt, Constanze N E Planck, Taufiek K Rajab, David Hollemann, Christine Tapprich, Bernhard Krämer, Christian Wallwiener, Helmut Hierlemann, Rolf Zehbe and 2 more

Registry-linked trialAbstract readReview
PubMed Publisher
In one paragraph

Review in Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03660787 (Phase II Multi-center Randomized Double-blind Placebo-controlled Efficacy and Dose Ranging Trial of the Drug Product Seroguard, Solution), which is not on this map. Cited by 52 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03660787 phase2completednot on this mapstarted 2017, after this paper: background citation

Phase II Multi-center Randomized Double-blind Placebo-controlled Efficacy and Dose Ranging Trial of the Drug Product Seroguard, Solution (JSC Pharmasyntez, Russia) Used for the Prevention of Pelvic Adhesions

TypeinterventionalSponsorPharmasyntezRan2017 to 2018Enrolled114ConditionsAdhesionArmsSeroguard, Placebo
3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Tissue adhesion after surgical interventions (Review).Experimental and therapeutic medicine · 2025
    Review
  9. Exploring the Potential of HCurrent pharmaceutical design · 2025
    Review
  10. Review
  11. Article
  12. Review
  13. Materials (Basel, Switzerland) · 2023
    Article
  14. Article
  15. Article
  16. Article
  17. Preventive effect of fucoxanthin administration on intra-abdominal adhesion: An experimental animal study.Ulusal travma ve acil cerrahi dergisi = Turkish journal of trauma & emergency surgery : TJTES · 2022
    Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Christoph BrochhausenREPAIR-lab, Institute of Pathology, University Medical Centre, Johannes Gutenberg-University, Langenbeckstraße 1,55101 Mainz, Germany. brochhausen@pathologie.klinik.uni-mainz.de
Volker H Schmitt
Constanze N E Planck
Taufiek K Rajab
David Hollemann
Christine Tapprich
Bernhard Krämer
Christian Wallwiener
Helmut Hierlemann
Rolf Zehbe
Heinrich Planck
C James Kirkpatrick

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe formation of peritoneal adhesions still is a relevant clinical problem after abdominal surgery. Until today, the most important clinical strategies for adhesion prevention are accurate surgical technique and the physical separation of traumatized serosal areas. Despite a variety of barriers which are available in clinical use, the optimal material has not yet been found. DISCUSSION: Mesothelial cells play a crucial physiological role in friction less gliding of the serosa and the maintenance of anantiadhesive surface. The formation of postoperative adhesions results from a cascade of events and is regulated by various cellular and humoral factors. Therefore, optimization or functionalization of barrier materials by developments interacting with this cascade on a structural or pharmacological level could give an innovative input for future strategies in peritoneal adhesion prevention. For this purpose, the proper understanding of the formal pathogenesis of adhesion formation is essential. Based on the physiology of the serosa and the pathophysiology of adhesion formation, the available barriers in current clinical practice as well as new innovations are discussed in the present review.

Indexed as

Practice Guidelines as TopicDigestive System Surgical ProceduresHumansMinimally Invasive Surgical ProceduresPeritoneal DiseasesPeritoneumTissue Adhesions

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.